{"id":3635,"count":8,"description":"Antitrombotika p\u0159edch\u00e1zej\u00ed a l\u00e9\u010d\u00ed krevn\u00ed sra\u017eeniny \u2014 \u017eiln\u00ed tromboembolii (hlubok\u00e1 \u017eiln\u00ed tromb\u00f3za, plicn\u00ed embolie), prevenci c\u00e9vn\u00ed mozkov\u00e9 p\u0159\u00edhody p\u0159i fibrilaci s\u00edn\u00ed, mechanick\u00e9 srde\u010dn\u00ed chlopn\u011b a arteri\u00e1ln\u00ed p\u0159\u00edhody jako je infarkt myokardu a ischemick\u00e1 c\u00e9vn\u00ed mozkov\u00e1 p\u0159\u00edhoda. Katalog antikoagulanci\u00ed MedsBase zahrnuje t\u0159i farmakologicky odli\u0161n\u00e9 skupiny: antagonisty vitaminu K (warfarin), p\u0159\u00edm\u00e1 peror\u00e1ln\u00ed antikoagulancia (DOACs) a antiagregancia.\n\n<strong>Antagonist\u00e9 vitaminu K.<\/strong> Warfarin z\u016fst\u00e1v\u00e1 standardem pro mechanick\u00e9 srde\u010dn\u00ed chlopn\u011b a cennou volbou u fibrilace s\u00edn\u00ed a \u017eiln\u00ed tromboembolie, kde jsou DOACs kontraindikov\u00e1ny (t\u011b\u017ek\u00e9 ren\u00e1ln\u00ed po\u0161kozen\u00ed, antifosfolipidov\u00fd syndrom, pokro\u010dil\u00e9 onemocn\u011bn\u00ed jater). Vy\u017eaduje pravideln\u00e9 monitorov\u00e1n\u00ed INR (c\u00edlov\u00e9 hodnoty 2,0\u20133,0 pro fibrilaci s\u00edn\u00ed a \u017eiln\u00ed tromboembolii; 2,5\u20133,5 pro mechanick\u00e9 mitr\u00e1ln\u00ed chlopn\u011b) a pe\u010dliv\u00e9 sledov\u00e1n\u00ed p\u0159\u00edjmu vitaminu K v potrav\u011b, antibiotik, NSAID, amiodaronu a mnoha dal\u0161\u00edch interaguj\u00edc\u00edch l\u00e1tek. Nab\u00edz\u00edme <a href=\"https:\/\/medsbase.com\/cs\/warf\/\">Warf<\/a> (1, 2, 3, 5 mg) a <a href=\"https:\/\/medsbase.com\/cs\/waf-5\/\">Waf-5<\/a> (5 mg).\n\n<strong>P\u0159\u00edm\u00e1 peror\u00e1ln\u00ed antikoagulancia (DOACs).<\/strong> DOACs jsou prvn\u00ed volbou pro prevenci c\u00e9vn\u00ed mozkov\u00e9 p\u0159\u00edhody u nevalvul\u00e1rn\u00ed fibrilace s\u00edn\u00ed a pro l\u00e9\u010dbu \u017eiln\u00ed tromboembolie u v\u011bt\u0161iny pacient\u016f, s praktick\u00fdmi v\u00fdhodami fixn\u00edho d\u00e1vkov\u00e1n\u00ed, absence rutinn\u00edho monitorov\u00e1n\u00ed a m\u00e9n\u011b interakcemi s potravou\/l\u00e9ky ne\u017e warfarin. Rivaroxaban (inhibitor faktoru Xa, jednou denn\u011b pro fibrilaci s\u00edn\u00ed a 15 mg dvakr\u00e1t denn\u011b, pot\u00e9 20 mg jednou denn\u011b pro \u017eiln\u00ed tromboembolii) je k dispozici jako. Apixaban (inhibitor faktoru Xa, dvakr\u00e1t denn\u011b, nejni\u017e\u0161\u00ed m\u00edra z\u00e1va\u017en\u00e9ho krv\u00e1cen\u00ed ve t\u0159\u00edd\u011b v p\u0159\u00edm\u00fdch studi\u00edch fibrilace s\u00edn\u00ed) je k dispozici jako <a href=\"https:\/\/medsbase.com\/cs\/xarelto-20\/\">Sluch\u00e1tka<\/a>. Antiagregancia. <a href=\"https:\/\/medsbase.com\/cs\/eliquis\/\">Eliquis<\/a>.\n\n<strong>Antiplatelet agents.<\/strong> Antiagregancia zabra\u0148uj\u00ed arteri\u00e1ln\u00ed tromb\u00f3ze (po IM, po PCI, ischemick\u00e9 c\u00e9vn\u00ed mozkov\u00e9 p\u0159\u00edhod\u011b, perifern\u00edm arteri\u00e1ln\u00edm onemocn\u011bn\u00ed). Klopidogrel (inhibitor P2Y12) je skladem jako <a href=\"https:\/\/medsbase.com\/cs\/clodict\/\">Clodict<\/a>. Du\u00e1ln\u00ed antiagrega\u010dn\u00ed terapie (kyselina acetylsalicylov\u00e1 + klopidogrel) je standardn\u00ed 6\u201312m\u011bs\u00ed\u010dn\u00ed re\u017eim po koron\u00e1rn\u00ed stentaci, n\u00e1sledovan\u00fd celo\u017eivotn\u00ed monoterapi\u00ed kyselinou acetylsalicylovou, pokud nen\u00ed kontraindikov\u00e1na.\n\n<strong>Heparin (parenter\u00e1ln\u00ed).<\/strong> Nefrakcionovan\u00fd heparin (Stanhep 25, 5000 IU\/ml) se pou\u017e\u00edv\u00e1 pro nemocni\u010dn\u00ed antikoagulaci, perioperativn\u00ed p\u0159echod, dialyza\u010dn\u00ed okruhy a akutn\u00ed VTE. N\u00edzkomolekul\u00e1rn\u00ed hepariny (enoxaparin, dalteparin) jsou \u0161iroce pou\u017e\u00edv\u00e1ny pro ambulantn\u00ed prevenci a l\u00e9\u010dbu VTE, ale jsou uvedeny samostatn\u011b, pokud jsou skladem.\n\n<strong>Antiparazitika.<\/strong> Pozn\u00e1mka: tento katalog v sou\u010dasn\u00e9 dob\u011b obsahuje tak\u00e9 \u0159adu produkt\u016f z p\u0159ilehl\u00fdch terapeutick\u00fdch oblast\u00ed \u2013 antiparazitika (Ivecop \/ Vermact ivermektin) je nejl\u00e9pe proch\u00e1zet v na\u0161\u00ed kategorii L\u00e9\u010dba roup\u016f a n\u011bkolik l\u00e9k\u016f na krevn\u00ed tlak (ramipril, olmesartan, losartan, propranolol, metoprolol) je spr\u00e1vn\u011b uvedeno v sekci L\u00e9ky na srdce a krevn\u00ed tlak. Tento katalog reorganizujeme, aby byly antitrombotika pohromad\u011b na jednom m\u00edst\u011b.\n\n<strong>Jak vybrat.<\/strong> Pro prevenci c\u00e9vn\u00ed mozkov\u00e9 p\u0159\u00edhody u nevalvul\u00e1rn\u00ed fibrilace s\u00edn\u00ed a v\u011bt\u0161iny VTE je up\u0159ednost\u0148ov\u00e1n DOAC p\u0159ed warfarinem (ni\u017e\u0161\u00ed riziko intrakrani\u00e1ln\u00edho krv\u00e1cen\u00ed, \u017e\u00e1dn\u00e9 monitorov\u00e1n\u00ed), pokud clearance kreatininu nen\u00ed ni\u017e\u0161\u00ed ne\u017e 25\u201330 ml\/min, pacient nem\u00e1 tripozitivn\u00ed antifosfolipidov\u00fd syndrom nebo mechanickou chlope\u0148 \u2013 v t\u011bchto p\u0159\u00edpadech z\u016fst\u00e1v\u00e1 warfarin l\u00e9kem prvn\u00ed volby. U arteri\u00e1ln\u00edch p\u0159\u00edhod je jedin\u00e9 antiagregancium (kyselina acetylsalicylov\u00e1 nebo klopidogrel) standardn\u00ed sekund\u00e1rn\u00ed prevenc\u00ed; du\u00e1ln\u00ed antiagrega\u010dn\u00ed terapie je \u010dasov\u011b omezen\u00e1 a indikac\u00ed \u0159\u00edzen\u00e1.\n\n<strong>Kritick\u00e1 varov\u00e1n\u00ed.<\/strong> All anticoagulants carry bleeding risk; report unusual bruising, gum bleeding, blood in urine or stool, severe headache, or any trauma immediately. Do not combine with NSAIDs (ibuprofen, diclofenac, naproxen) without medical advice \u2014 significant bleed-risk amplification. Major surgery, dental extraction, or invasive procedures need planned interruption (5 days for warfarin, 24\u201348 hours for DOACs depending on renal function and bleed risk). Pregnancy: warfarin is teratogenic; DOACs are not recommended in pregnancy or breastfeeding \u2014 switch to LMWH under haematology guidance.\n\nAll MedsBase Anti-Coagulants ship from <strong>WHO-GMP certifikovan\u00fdch v\u00fdrobc\u016f<\/strong> s diskr\u00e9tn\u00edm celosv\u011btov\u00fdm doru\u010den\u00edm a jsou chr\u00e1n\u011bny na\u0161\u00edm <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\">Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/a>.","link":"https:\/\/medsbase.com\/cs\/anti-coagulants\/","name":"Antikoagulancia","slug":"anti-coagulants","taxonomy":"product_cat","parent":3342,"meta":[],"menu_order":0,"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat\/3635","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/taxonomies\/product_cat"}],"up":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat\/3342"}],"wp:post_type":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product?product_cat=3635"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}